Skip to content
  1. Home
  2. Latest news
  3. Statement on the release of the Janssen U.S. Transparency Report
Beerse Scientists

Statement on the release of the Janssen U.S. Transparency Report

Below, please find a statement on the Janssen U.S. Transparency Report from Joaquin Duato, Johnson & Johnson Executive Vice President and Worldwide Chairman, Pharmaceuticals. You can view the full report on Janssen.com.

“We are pleased to release the inaugural Janssen U.S. Transparency Report, in which we are disclosing more information about our business practices, including those related to pricing. This report builds on our history of responsible pricing practices and our ongoing efforts to provide more transparency into how we operate. These disclosures are steps that we can take as one company as we continue to work with others in the health care system to address stakeholder concerns about U.S. health care costs.” - Joaquin Duato, Executive Vice President and Worldwide Chairman, Pharmaceuticals

More from Johnson & Johnson

Johnson & Johnson named a 2025 Fortune World’s Most Admired Company

A dedication to innovation and social responsibility are just two of the qualities that helped the company garner a coveted spot on the list for the 23rd year in a row.

What you need to know about Johnson & Johnson’s 2024 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and full-year performance, with highlights from its Innovative Medicine and MedTech businesses.

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.